Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Diagnostics Genetics and epigenetics, Biochemistry and molecular biology, Neurology, Omics

Exploring the Epi-signature

“Do patients with intellectual disabilities have identifiable and specific changes in their epigenomes – and can we find the answer in peripheral blood?” This is the question that Bekim Sadikovic, Head of Molecular Genetics at London Health Sciences Center (LHSC) in Canada, posed in a recent article on the potential diagnostic power of DNA methylation (1). At the time, evidence showed that significant genome-wide DNA methylation alterations could be detected in peripheral blood, providing hope that DNA methylation tests could determine whether a variant of unknown significance is pathogenic. But, 18 months on, how much progress has Sadikovic – and the field as a whole – made?

His latest research applies the technique to DNA samples from patients with neurodevelopmental and congenital anomalies who lacked a definitive diagnosis (2). “Currently, the more sophisticated genetic analyses produce a 30–35 percent diagnostic yield for patients who present with developmental disabilities, leaving many cases unexplained,” Sadikovic says. “When we applied genome-wide DNA methylation analysis, we were able to diagnose a significant number of additional patients in whom we identified an underpinning genetic condition based on evidence of an epigenetic defect.”

The team has demonstrated that genetic defects can be manifested either as a result of, or in association with, genome-wide DNA methylation patterns. When these methylation defects occur across multiple loci, they are referred to as epi-signatures. “We can compare these epi-signatures to our reference database, which contains data for various conditions, to identify underlying genetic defects,” explains Sadikovic.

We’re reaching a plateau in terms of what we can do using genomics and DNA sequencing – but what we’re now doing is moving the technology from research into the clinic.

In the new study, a computational model facilitated the concurrent detection of 14 syndromes with over 99 percent accuracy. Across 965 undiagnosed patients, the model identified 15 subjects with syndromic Mendelian disorders, 12 with imprinting and trinucleotide repeat expansion disorders, and 106 with rare epi-variants. “For the last couple of decades, genomics has been at the forefront of molecular diagnostics. We’re reaching a plateau in terms of what we can do using genomics and DNA sequencing – but what we’re now doing is moving the technology from research into the clinic.”

As the first site in the world to offer this form of genetic testing, Sadikovic hopes that the work at LHSC sets a precedent. “The technology is easily accessible and most labs already have the ability to run genomic testing. The challenge will be interpreting the data. We have already built large reference databases to map epi-genetic signatures – and hopefully these continue to grow as the technology becomes more widespread.”

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. Bekim Sadikovic, “The Diagnostic Power of DNA Methylation”, The Pathologist (2018). Available at: bit.ly/2mmzJ41.
  2. Aref-Eshghi et al., “Diagnostic utility of genome-wide DNA methylation testing in genetically unsolved individuals with suspected hereditary conditions”, Am J Hum Genet, 104, 685, (2019). PMID: 30929737.
About the Author
Luke Turner

While completing my undergraduate degree in Biology, I soon discovered that my passion and strength was for writing about science rather than working in the lab. My master’s degree in Science Communication allowed me to develop my science writing skills and I was lucky enough to come to Texere Publishing straight from University. Here I am given the opportunity to write about cutting edge research and engage with leading scientists, while also being part of a fantastic team!

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register